Erbitux for Head and Neck Cancer User Reviews
- ELM...
- October 16, 2015
"I heard good things about this drug for metastatic head and neck cancer (mine began in my tongue and has moved around my mouth and into my neck - I'm a 30-year-old female with no risk factors), but had a severe allergic reaction during my first infusion. I felt a hot flash move from my midsection to my head, then everything started swelling until finally my throat began to close. It was instantaneous. I only had about 10-20 cc's. Luckily, my nurse was prepared and flushed the line immediately and gave me meds to stop the reaction. My doctor has already ordered panitumumab to replace it."
See also:
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Libtayo
Libtayo (cemiplimab-rwlc) is used to treat metastatic cutaneous squamous cell carcinoma, basal cell ...
Blenoxane
Blenoxane is used for hodgkin's lymphoma, non-hodgkin's lymphoma, squamous cell carcinoma ...
Unloxcyt
Unloxcyt (cosibelimab-ipdl) is an anti-PD-1 treatment for metastatic or advanced cutaneous squamous ...
Cemiplimab
Cemiplimab is used for basal cell carcinoma, non small cell lung cancer, squamous cell carcinoma
Bleomycin
Bleomycin is used for hodgkin's lymphoma, malignant pleural effusion, non-hodgkin's lymphoma ...
Pembrolizumab
Pembrolizumab (Keytruda) is a monoclonal antibody cancer medicine used to treat
Are you taking this medicine?
Your review helps others make informed decisions.More about Erbitux (cetuximab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (9)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
"My father-in-law was diagnosed with metastatic squamous cell head and neck cancer. Had 6 weeks of radiation, but cancer had spread. Conventional chemo did nothing. Had large tumors, one breaking through the chest wall. Could not do daily tasks. He started on Erbitux infusions, and within four weeks, two of the tumors had disappeared, and the larger ones had shrunk. Didn't need pain medicines anymore. Side effects he experienced: blood infections from the PICC line, electrolyte imbalance, rash on his body. He is happy with the drug. He has lived several months longer than anticipated, but he must stay on Erbitux or the cancer will come back."